ACB
CCRN

Aristotle Capital Boston’s Cross Country Healthcare CCRN Stock Holding History

Aristotle Capital Boston’s Portfolio CCRN Stock Details CCRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.97M Sell
529,036
-97,071
-16% -$869K 0.31% 98
2025
Q4 		$5.07M Sell
626,107
-62,889
-9% -$687K 0.28% 100
2025
Q3 		$9.78M Sell
688,996
-8,106
-1% -$107K 0.5% 82
2025
Q2 		$9.1M Sell
697,102
-38,639
-5% -$531K 0.46% 80
2025
Q1 		$11M Sell
735,741
-124,954
-15% -$2.15M 0.55% 74
2024
Q4 		$15.6M Sell
860,695
-96,730
-10% -$1.3M 0.58% 70
2024
Q3 		$12.9M Buy
957,425
+49,864
+5% +$735K 0.43% 83
2024
Q2 		$12.6M Sell
907,561
-14,202
-2% -$225K 0.42% 83
2024
Q1 		$17.3M Buy
921,763
+7,969
+0.9% +$159K 0.52% 74
2023
Q4 		$20.7M Buy
913,794
+23,391
+3% +$507K 0.63% 72
2023
Q3 		$22.1M Buy
890,403
+2,831
+0.3% +$71.2K 0.71% 58
2023
Q2 		$24.9M Buy
887,572
+11,481
+1% +$285K 0.75% 54
2023
Q1 		$19.6M Sell
876,091
-216,424
-20% -$5.67M 0.6% 69
2022
Q4 		$29M Sell
1,092,515
-472,194
-30% -$15.4M 0.92% 46
2022
Q3 		$44.4M Sell
1,564,709
-73,903
-5% -$1.9M 1.5% 9
2022
Q2 		$34.1M Buy
1,638,612
+86,397
+6% +$1.62M 1.02% 34
2022
Q1 		$33.6M Sell
1,552,215
-57,156
-4% -$1.24M 0.85% 49
2021
Q4 		$44.7M Sell
1,609,371
-14,175
-0.9% -$344K 1.05% 33
2021
Q3 		$34.5M Sell
1,623,546
-452,840
-22% -$8.49M 0.81% 53
2021
Q2 		$34.3M Sell
2,076,386
-411,839
-17% -$6.29M 0.78% 50
2021
Q1 		$31.1M Buy
2,488,225
+14,854
+0.6% +$157K 0.69% 60
2020
Q4 		$21.9M Sell
2,473,371
-65,444
-3% -$532K 0.52% 86
2020
Q3 		$16.5M Sell
2,538,815
-374,422
-13% -$2.37M 0.48% 86
2020
Q2 		$17.9M Buy
2,913,237
+293,248
+11% +$1.8M 0.55% 73
2020
Q1 		$17.7M Sell
2,619,989
-76,382
-3% -$724K 0.76% 52
2019
Q4 		$31.3M Buy
2,696,371
+123,249
+5% +$1.39M 0.86% 48
2019
Q3 		$26.5M Buy
2,573,122
+257,053
+11% +$2.53M 0.78% 52
2019
Q2 		$21.7M Buy
2,316,069
+46,349
+2% +$357K 0.68% 64
2019
Q1 		$16M Buy
2,269,720
+1,142,815
+101% +$9.79M 0.53% 84
2018
Q4 		$8.26M Buy
1,126,905
+125,669
+13% +$1.05M 0.68% 68
2018
Q3 		$8.74M Buy
1,001,236
+48,182
+5% +$492K 0.64% 75
2018
Q2 		$10.7M Sell
953,054
-547,849
-37% -$6.53M 0.85% 62
2018
Q1 		$16.7M Buy
1,500,903
+535,936
+56% +$6.72M 0.78% 53
2017
Q4 		$12.3M Buy
964,967
+202,767
+27% +$2.68M 0.9% 44
2017
Q3 		$10.8M Buy
762,200
+172,018
+29% +$2.15M 0.97% 39
2017
Q2 		$7.62M Buy
590,182
+114,395
+24% +$1.47M 0.85% 55
2017
Q1 		$6.83M Buy
475,787
+42,656
+10% +$628K 0.91% 43
2016
Q4 		$6.76M Buy
433,131
+42,023
+11% +$575K 0.93% 43
2016
Q3 		$4.61M Buy
391,108
+43,914
+13% +$578K 0.82% 57
2016
Q2 		$4.83M Buy
347,194
+12,438
+4% +$165K 0.94% 45
2016
Q1 		$3.89M Buy
334,756
+8,014
+2% +$102K 0.78% 64
2015
Q4 		$5.36M Buy
326,742
+76,945
+31% +$1.22M 1.09% 33
2015
Q3 		$3.4M Buy
249,797
+10,715
+4% +$146K 0.83% 55
2015
Q2 		$3.03M Buy
239,082
+63,363
+36% +$718K 0.69% 72
2015
Q1 		$2.08M Buy
175,719
+57,445
+49% +$658K 0.65% 78
2014
Q4 		$1.48M Buy
+118,274
New +$1.21M 0.74% 65

Other funds holding CCRN

Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
QOP
Quinn Opportunity Partners Charlottesville, Virginia $1.92B AUM 31.26% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
OBAM
ODDO BHF Asset Management Paris, France $2.54B AUM 41.83% 1-Year Est. Return
DIA
Dana Investment Advisors Waukesha, Wisconsin $3.35B AUM 29.65% 1-Year Est. Return

Aristotle Capital Boston's CCRN Position: Q1 2026 in Review

Aristotle Capital Boston reduced its Cross Country Healthcare (CCRN) stake by 16% in Q1 2026, selling an estimated $869K and leaving 529,036 shares worth $4.97M. The position accounts for 0.31% of the portfolio, ranked #98.

Aristotle Capital Boston first reported a position in CCRN in Q4 2014 and has held it in 46 quarters since. The position peaked at $44.7M in Q4 2021. 151 funds tracked by Wall St. Rank hold CCRN as of Q1 2026.

  • Aristotle Capital Boston held 529,036 shares of Cross Country Healthcare worth $4.97M as of Q1 2026.
  • Aristotle Capital Boston sold 97,071 Cross Country Healthcare shares in Q1 2026, an estimated $869K.
  • Cross Country Healthcare made up 0.31% of Aristotle Capital Boston's portfolio in Q1 2026, its #98 holding.
  • Aristotle Capital Boston first reported a position in Cross Country Healthcare in Q4 2014 and has held it in 46 quarters since.
  • Aristotle Capital Boston's Cross Country Healthcare position peaked at $44.7M in Q4 2021.
  • 151 funds tracked by Wall St. Rank held Cross Country Healthcare as of Q1 2026.

Based on Aristotle Capital Boston's 13F filing for Q1 2026, filed 15 May 2026.